Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substitued [1,2,4]triazolo[1,5-a]pyrazines as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes

Substitued [1,2,4]triazolo[1,5-a]pyrazines as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes

US Patent 7812027 · Granted Oct 12, 2010

Estimated economic value: $104,397,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Glucose-responsive insulin conjugates2025
NK3 modulators and uses thereof2025
Tricyclic pyridones and pyrimidones2024
Bottle2024
AMPK activators2023
Tricyclic pyridones and pyrimidones2023
Conjugate based systems for controlled insulin delivery2023
Chromane monobactam compounds for the treatment of bacterial infections2022
Biaryl monobactam compounds and methods of use thereof for the treatment of bact2022
Glucose responsive insulin comprising a tri-valent sugar cluster for treatment o2021
Insulin receptor partial agonists2020
Insulin receptor partial agonists2020